Bile duct cancer patients who have survived for over 5 years: These 3 signs indicate that they are improving

When malignant tumors recur and metastasize, the body often gives us hints, such as symptoms like bleeding, swollen lymph nodes, fever, weight loss, and pain. If a patient does not show any of the above obvious signs of recurrence, it means that the body is in the process of recovery, the trend and risk of cancer are decreasing, and the possibility of cancer recurrence is reduced. Therefore, the stability of life and health is gradually improving.

Ms. Zhang's physical strength has recovered to the level before she got sick, her mental state is full, and her normal work and life have not been affected by the disease.

Looking back at Ms. Zhang's treatment journey, it is not difficult to observe that three key indicators - stable and normal laboratory results, no recurrence signals observed in imaging, and no abnormal discomfort in the body - collectively form the foundation for her sustained improvement. These indicators not only affirm her personal efforts but also serve as strong evidence for the effectiveness of vNKT cell therapy. The incidence of local recurrence and distant metastasis after surgery for hepatocellular carcinoma is 60% to 70%[1]. After surgery, Ms. Zhang adopted vNKT cell therapy as a powerful supplement to traditional treatment. It not only clears residual tumor cells from the body but also rebuilds the immune system and prevents the occurrence of micrometastasis, thus achieving stability for nearly five years post-surgery.

However, we must also recognize that the journey against cancer is never smooth sailing. Each patient's condition is unique, making the development of personalized treatment plans crucial. Ms. Zhang's successful case tells us that when facing cancer, we need to combine our own condition, actively seek appropriate treatment methods, and persist in treatment. Finally, I wish every patient can overcome these three major hurdles and move towards recovery.

Benefits Sharing

         

If you are currently in a confusing stage of tumor treatment and have doubts about treatment methods and plans, you can add Lehe and Little Assistant. Lehe and New Medicine will provide you with free consultation services.

       

         

Lian

is a

I     

       

Scan QR code

Communicate with Professor Zhang Minghui's team

References:

[1] Ying Songsong, Gao Zhiyan. Progress in the diagnosis and treatment of intrahepatic cholangiocarcinoma [J]. Guangzhou Medical Journal, 2023, 54(06): 100-105.

     

     

         

         

Zhang Minghui

Founder of Lehe New Medicine

         

Professor Zhang Minghui, a Ph.D. in Immunology from Tsinghua University School of Medicine, has led a research team for over 20 years since the discovery of vNKT cells in 2002. They have accumulated treatment experience in over 700 cases of solid tumors, covering almost all common types of solid tumors. The research results fully demonstrate the great value of vNKT in the treatment of solid tumors.

It is suitable for postoperative patients with high pathological malignancy or a risk of recurrence; patients whose tumors have been basically controlled but not cured through conventional treatments such as chemotherapy, radiotherapy, and targeted therapy; patients with persistent high carcinogenic factors; and patients intolerant to radiotherapy and chemotherapy.If these patients do not receive effective follow-up treatment after traditional anti-tumor therapy, the recurrence, metastasis, or re-emergence of tumors will be highly probable. In this case, vNKT cell therapy is an ideal follow-up treatment method, which can significantly improve the prognosis of patients.

Written by: Tuantuan

Reviewed by: Qiao Jiacheng, Wang Ying, Gao Chen

Edited/typeset by Zhang Jiao

   

Click on the image to view past exciting content

                     

         

         

         

         

             

What the fairies are watching

Click on the upper right corner of the homepage · · · Set as Starred !